http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2091057-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 |
filingDate | 1991-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b68d5e6a9b166daa28990343fe6912e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bb94f8d926e0945cb033239d3731622 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f7661cd9c8a1f025082bb8bb1b9bc9b |
publicationDate | 1992-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-2091057-A1 |
titleOfInvention | Substituted 6,7-dihydroimidazo(1,5,4-ef) (1,5) benzodiazepin-6-ones, their preparation and pharmaceutical compositions |
abstract | Platelet activating factor antagonists of formula (I), wherein R1 is H or C1-C4 alkyl optionally substituted by a substituent selected from phenyl, halophenyl, pyridyl, (C1-C4 alkoxy) carbonyl and di-(C1-C4 alkyl) amino, or is C2-C4 alkyl substituted by hydroxyl or by one ore two C1-C4 alkoxy groups or is (CH2)nCONR7R8 where n is an integer from 1 to 4 and R7 and R8 are each independently H or C1-C4 alkyl, R2 is selected from H, OH and C1-C4 alkyl, R3 is selected from halo and C1-C4 alkyl, R4 is methyl, and p is an integer from 0 to 3 and m is an integer from 0 to 3; or a pharmaceutically acceptable salt thereof. |
priorityDate | 1990-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 48.